Immutep Ltd Adr Stock Annual Yield
| IMMP Stock | USD 1.93 0.03 1.58% |
Immutep Ltd ADR fundamentals help investors to digest information that contributes to Immutep's financial success or failures. It also enables traders to predict the movement of Immutep Stock. The fundamental analysis module provides a way to measure Immutep's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Immutep stock.
Immutep | Annual Yield |
Immutep Ltd ADR Company Annual Yield Analysis
Immutep's Yield generally refers to the amount of cash that is paid back to the owner of a security over a specific time (usually one year). It is expressed as a percentage of current market price, and usually amounts to all the interests and/or dividends paid over a given period. A higher yield allows the shareholders to generate returns on their investments sooner. However, investors should also be aware that a high yield may be a result of market turmoil or increased price volatility.
Immutep Annual Yield Driver Correlations
Understanding the fundamental principles of building solid financial models for Immutep is extremely important. It helps to project a fair market value of Immutep Stock properly, considering its historical fundamentals such as Annual Yield. Since Immutep's main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Immutep's historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Immutep's interrelated accounts and indicators.
Click cells to compare fundamentals
Small firms, start-ups, or companies with high growth potential typically do not pay out dividends or distribute a lot of their profits. These companies will have small yield. Alternatively, more established companies, ETFs, and funds that invest in bonds will have higher yields.
| Competition |
In accordance with the recently published financial statements, Immutep Ltd ADR has an Annual Yield of 0.0%. This indicator is about the same for the Biotechnology average (which is currently at 0.0) sector and about the same as Health Care (which currently averages 0.0) industry. This indicator is about the same for all United States stocks average (which is currently at 0.0).
Immutep Current Valuation Drivers
We derive many important indicators used in calculating different scores of Immutep from analyzing Immutep's financial statements. These drivers represent accounts that assess Immutep's ability to generate profits relative to its revenue, operating costs, and shareholders' equity. Below are some of Immutep's important valuation drivers and their relationship over time.
| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 (projected) | ||
| Market Cap | 61.8M | 310.2M | 229.8M | 257.6M | 296.2M | 414.3M | |
| Enterprise Value | 44.5M | 252.9M | 151.6M | 135.4M | 155.7M | 147.9M |
Immutep Fundamentals
| Return On Equity | -0.26 | ||||
| Return On Asset | -0.17 | ||||
| Operating Margin | (13.53) % | ||||
| Current Valuation | 185.09 M | ||||
| Shares Outstanding | 145.46 M | ||||
| Shares Owned By Insiders | 0.01 % | ||||
| Shares Owned By Institutions | 4.76 % | ||||
| Number Of Shares Shorted | 5.09 M | ||||
| Price To Earning | (152.55) X | ||||
| Price To Book | 2.59 X | ||||
| Price To Sales | 73.07 X | ||||
| Revenue | 3.84 M | ||||
| Gross Profit | (37.7 M) | ||||
| EBITDA | (44.54 M) | ||||
| Net Income | (42.72 M) | ||||
| Cash And Equivalents | 80 M | ||||
| Cash Per Share | 0.92 X | ||||
| Total Debt | 1.59 M | ||||
| Debt To Equity | 0.02 % | ||||
| Current Ratio | 14.16 X | ||||
| Book Value Per Share | 0.13 X | ||||
| Cash Flow From Operations | (34.82 M) | ||||
| Short Ratio | 65.76 X | ||||
| Earnings Per Share | (0.21) X | ||||
| Target Price | 9.5 | ||||
| Beta | 1.9 | ||||
| Market Capitalization | 280.73 M | ||||
| Total Asset | 201.58 M | ||||
| Retained Earnings | (382.65 M) | ||||
| Working Capital | 180.86 M | ||||
| Current Asset | 1.89 M | ||||
| Current Liabilities | 1.04 M | ||||
| Net Asset | 201.58 M |
About Immutep Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Immutep Ltd ADR's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Immutep using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Immutep Ltd ADR based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Additional Tools for Immutep Stock Analysis
When running Immutep's price analysis, check to measure Immutep's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Immutep is operating at the current time. Most of Immutep's value examination focuses on studying past and present price action to predict the probability of Immutep's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Immutep's price. Additionally, you may evaluate how the addition of Immutep to your portfolios can decrease your overall portfolio volatility.